Inflammatory Response clinical trials

Explore recruiting inflammatory response clinical trials.

Recruiting inflammatory response studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Inflammatory Response trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PANACEA : Effect of PrehAbilitation by NutritionAl supplementation with Cannabidiol on skeletal muscle mass and mitochondrial function in hEad and neck cAncer : a proof of concept controlled randomized trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A model of a sterile, self-limiting, acute inflammatory response in healthy volunteers using lipopolysaccharides – a platform trial

Austria

Human Pharmacology (Phase I)- Other EU CTIS Study details

Immunomodulatory effects of dexamethasone, tocilizumab and anakinra during experimental human endotoxemia: the DEDICATE-LPS study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Colchicine to Quench the Inflammatory Response after Deep Vein Thrombosis: The CONQUER-DVT Randomized Controlled Trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of infLuenza vaccInation after Myocardial INfArction on cardiac inflammaTory responsE - a randomized, double-blind, placebo-controlled, trial (ELIMINATE trial)

Sweden, Denmark

Therapeutic use (Phase IV) EU CTIS Study details

An investigation of clinical outcomes and inflammatory response to heparin free extracorporeal membrane oxygenation support during clinical lung transplantation – a prospective double-blind randomised feasibility study. “Zero-Hep”

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Inflammatory Response trials by city

Inflammatory Response in Toronto Inflammatory Response in Vancouver Inflammatory Response in Montreal Inflammatory Response in Calgary Inflammatory Response in Edmonton Inflammatory Response in Ottawa Inflammatory Response in Winnipeg Inflammatory Response in Quebec City Inflammatory Response in Hamilton Inflammatory Response in Kitchener Inflammatory Response in London Inflammatory Response in Halifax Inflammatory Response in New York Inflammatory Response in Los Angeles Inflammatory Response in Chicago Inflammatory Response in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease